Skip to main content
. 2018 Jun 19;9(47):28421–28433. doi: 10.18632/oncotarget.25420

Table 3. Significantly differentially altered genes across all analyses.

Typical responders Exceptional responders
Copy number VSTM2A
LOC285878
OR4M2
OR4N4
CDKN2A-AS1
CDKN2A
Methylation SLC15A3
TTC12
LRRC8E
SUSD3
LRRC61
Gene expression CXCL8
CCL20
ETNPPL
SH3GL2
GSEA LAG3
SFTPD
INHBA
TRIB2
KLF4
NMI
NFKB1
INHBB
IL6
RNF128
BCL3
NLGN1
STXBP1
DNM1
PINK1
SYNJ1
CDK5
SCAMP5
CACNA1I
SYT1
KCNB1
PLCB1
CDK5R2
NOS1
CPM6B
TOR1A
CAMK2A
CACNA1A
RIMS1
KCNMB4
SNCG
MEF2C
SNCAIP
SYT11
ACCN2
NF1
RAB3A
RIMS3
SNCA
SYN1
RAB5A
RAB3GAP1
PFN2

The genes are separated by response group according to which group they are upregulated in. “Upregulated” for each data type is defined as: larger magnitude copy number gains/smaller magnitude copy number loss, lower promoter methylation, higher gene expression, and enrichment in GSEA.